- (2023): Nakao Y+, Pharmaceuticals (Basel) 16(10), 1500 (FDA Adverse Event Reporting System data)
Please login to view adverse reactions.
Hepatotoxicity / liver injury / acute liver injury / drug-induced liver injury (DILI)
Adverse effects / adverse reactions